BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 851454)

  • 1. Evidence of tumorigenic activity of candidate cell substrates in vaccine production by use of antilymphocyte serum.
    Glathe H; Abel C
    Dev Biol Stand; 1977; 34():145-8. PubMed ID: 851454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotransplantability testing in nude mice of candidate cell for vaccine production.
    Kairouannais M; Nicolas A
    Dev Biol Stand; 1980; 45():137-42. PubMed ID: 6967435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of cell culture tumorigenic activity by heterotransplantation into hamster cheek pouch tissue using immunodepressants].
    Avakova AN; Rozina EE; Stepanova LG; Andzhaparidze OG
    Vopr Virusol; 1976; (2):211-6. PubMed ID: 936580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of positive controls in testing the oncogenic potential of cell material for virus vaccine production.
    Rau C; Voiculescu C; Palade V
    Dev Biol Stand; 1976 Dec 13-15; 37():241-4. PubMed ID: 1031687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial transplantation of Burkitt's tumor (EB3) cells in newborn Syrian hamsters and its facilitation by antilymphocyte serum.
    Adams RA; Foley GE; Frber S; Flowers A; Lazarus H; Hellerstein EE
    Cancer Res; 1970 Feb; 30(2):338-45. PubMed ID: 4917979
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenesis in tissue culture 27: heterotransplantation as an alternative in vivo assay for neoplastic state of cells in culture.
    Sakakibara K; Takaoka T; Katsuta H
    Jpn J Exp Med; 1976 Aug; 46(4):457-62. PubMed ID: 1086916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Further use of antithymocyte serum].
    Huang NJ
    Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):244-6. PubMed ID: 4085311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumourigenicity testing in immunosuppressed mice: advantages and disadvantages.
    Stanbridge EJ; Perkins FT
    Dev Biol Stand; 1976 Dec 13-15; 37():211-7. PubMed ID: 1031686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity testing of various cell substrates for production of biologicals.
    Furesz J; Fanok A; Contreras G; Becker B
    Dev Biol Stand; 1989; 70():233-43. PubMed ID: 2759351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of the oncogenic activity of cell cultures using antithymocytic serum].
    Abel C; Glathe H
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(3):375-81. PubMed ID: 311797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL; Reif AE; Shklar G
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
    Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
    JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotransplantation of cell lines derived from human malignant neoplasms into golden hamsters treated with antithymocyte serum.
    Sakakibara K; Oota K
    Jpn J Exp Med; 1975 Dec; 45(6):501-14. PubMed ID: 1085379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay for cell tumorigenicity in subhuman primates treated with antilymphocyte globulin.
    Petricciani JC; Kirschstein RL; Wallace RE; Martin DP
    J Natl Cancer Inst; 1972 Mar; 48(3):705-13. PubMed ID: 4621740
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of controlled nuclear division in BHK21 cells passed in vivo.
    O'Neill FJ
    Cancer Res; 1976 Jun; 36(6):2019-24. PubMed ID: 944618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis in tissue culture 25: reduced tumorigenicity of alkaline phosphatase-constitutive variants from Chinese hamster ovary cells.
    Nose K; Sakakibara K
    Jpn J Exp Med; 1975 Oct; 45(5):327-34. PubMed ID: 1083437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity of a rabbit lymphoid cell line transformed by human T-cell leukemia virus.
    Miyoshi I; Kubonishi I; Yoshimoto S; Ohtsuki Y; Akagi T
    Gan; 1984 Jun; 75(6):482-4. PubMed ID: 6088346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
    Tatalick LM; Gerard CJ; Takeya R; Price DN; Thorne BA; Wyatt LM; Anklesaria P
    Vaccine; 2005 Apr; 23(20):2628-38. PubMed ID: 15780446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].
    Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG
    Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.